multi-epitope folate receptor alpha peptide vaccine
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2012 (NCT01606241)
Timeline
Indications
Mechanism of action
- Folate receptor alphaImmunity, active
FOLR1 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- multi-epitope folate receptor alpha peptide vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03012100 | Phase 2 | Mar 31, 2017 | Academic and Community Cancer Research United, National Cancer Institute (NCI) |
| NCT01606241 | Phase 1 | Jul 1, 2012 | Mayo Clinic, National Cancer Institute (NCI) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 2 | 0 | 2 | 2012 |
| Academic and Community Cancer Research United | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Mayo Clinic | Academic/Hospital | 1 | 1 | 1 | 2012 |
3 organizations
Page 1 / 1